Three-Dimensional Quantitative Structure - Activity Relationship Analyses of Peptide Substrates of the Mammalian H+/Peptide Cotransporter PEPT1

Journal of Medicinal Chemistry

Volumn 46, Issue 26, 2003, Pages 5725-5734

  Gebauer, Sabine ^a   Knütter, Ilka ^a   Hartrodt, Bianka ^a   Brandsch, Matthias ^a   Neubert, Klaus ^a   Thondorf, Iris ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COTRANSPORTER; DIPEPTIDE; PEPTIDE; PEPTIDE TRANSPORTER 1;

ARTICLE; BINDING AFFINITY; DRUG BIOAVAILABILITY; DRUG DESIGN; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

CARRIER PROTEINS; DIPEPTIDES; DRUG DESIGN; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

EID: 0346366456     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030976x     Document Type: Article

References (37)

1. Meredith, D.; Boyd, C. A. Structure and function of eukaryotic peptide transporters. Cell. Mol. Life Sci. 2000, 57, 754-758.
2. Fei, Y. J.; Ganapathy, V.; Leibach, F. H. Molecular and structural features of the proton-coupled oligopeptide transporter superfamily. Prog. Nucleic Acid Res. Mol. Biol. 1998, 58, 239-261.
3. Rubio-Aliaga, I.; Daniel, H. Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol. Sci. 2002, 23, 434-440.
4. +/ peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 1999, 16, 55-61.
5. Moore, V. A.; Irwin, W. J.; Timmins, P.; Lambert, P. A.; Chong, S.; Dando, S. A.; Morrison, R. A. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: Affinities of ACE inhibitors. Int. J. Pharm. 2000, 210, 29-44.
6. Ganapathy, M. E.; Huang, W.; Wang, H.; Ganapathy, V.; Leibach, F. H. Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem. Biophys. Res. Commun. 1998, 246, 470-475.
7. Nakanishi, T.; Tamai, I.; Takaki, A.; Tsuji, A. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Int. J. Cancer 2000, 88, 274-280.
8. Lee, H. J.; Amidon, G. L. Oral peptide delivery: Improving the systemic availability of small peptides and enkephalin analogues. NIDA Res. Monogr. 1995, 154, 86-106.
9. Meredith, D.; Temple, C. S.; Guha, N.; Sword, C. J.; Boyd, C. A.; Collier, I. D.; Morgan, K. M.; Bailey, P. D. Modified amino acids and peptides as substrates for the intestinal peptide transporter PEPT1. Eur. J. Biochem. 2000, 267, 3723-3728.
10. Brandsch, M.; Knütter, I.; Thunecke, F.; Hartrodt, B.; Born, I.; Borner, V.; Hirche, F.; Fischer, G.; Neubert, K. Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter. Eur. J. Biochem. 1999, 266, 502-508.
11. Döring, F.; Will, J.; Amasheh, S.; Clauss, W.; Ahlbrecht, H.; Daniel, H. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J. Biol. Chem. 1998, 273, 23211-23218.
12. Meredith, D.; Boyd, C. A.; Bronk, J. R.; Bailey, P. D.; Morgan, K. M.; Collier, I. D.; Temple, C. S. 4-aminomethylbenzoic acid is a nontranslocated competitive inhibitor of the epithelial peptide transporter PEPT1. J. Physiol. 1998, 512, 629-634.
13. Bailey, P. D.; Boyd, C. A.; Bronk, J. R.; Collier, I. D.; Meredith, D.; Morgan, K. M.; Temple, C. S. How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PEPT1. Angew. Chem., Int. Ed. Engl. 2000, 39, 505-508.
14. Swaan, P. W.; Koops, B. C.; Moret, E. E.; Tukker, J. J. Mapping the binding site of the small intestinal peptide carrier (PEPT1) using comparative molecular field analysis. Receptors Channels 1998, 6, 189-200.
15. +/ peptide cotransporters PEPT1 and PEPT2. Biochemistry 1997, 36, 452-460.
16. Döring, F.; Dorn D.; Bachfischer, U.; Amasheh, S.; Herget, M.; Daniel, H. Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms. J. Physiol. 1996, 497, 773-779.
17. Döring, F.; Walter, J.; Will, J.; Focking, M.; Boll, M.; Amasheh, S.; Clauss, W.; Daniel H. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J. Clin. Invest. 1998, 101, 2761-2767.
18. Brandsch, M.; Thunecke, F.; Küllertz, G.; Schutkowski, M.; Fischer, G.; Neubert, K. Evidence for the absolute conformational specificity of the intestinal H+/peptide symporter, PEPT1. J. Biol. Chem. 1998, 273, 3861-3864.
19. Hartrodt, B.; Theis, S.; Knütter, I.; Börner, V.; Born, I.; Brandsch, M.; Daniel, H.; Neubert, K. New insights into stereospecificity of the intestinal H+/peptide symporter. In Peptides 2000, Proceedings 26th Europ. Peptide Symposium; Martinez, J., Fehrentz, J.-A., Eds.; EDK Paris, France, 2001; pp 983-984.
20. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
21. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146.
22. Nicolotti, O.; Pellegrini-Calace, M.; Carrieri, A.; Altomare, C.; Centeno, N. B.; Sanz, F.; Carotti, A. Neuronal nicotinic receptor agonists: A multi-approach development of the pharmacophore. J. Comput.-Aided Mol. Des. 2001, 15, 859-872.
23. Martin, Y. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
24. Klebe, G. Comparative molecular similarity indices analysis: CoMSIA. Perspect. Drug Discovery Des. 1998, 12, 87-104.
25. Other diketopiperazines carrying either positively charged side chains or neutral groups do not show any appreciable binding affinity. Nevertheless, they have been included in the DISCO studies; however, they did not yield any features and have, therefore, been omitted from the 3D QSAR analyses.
26. Li, J.; Tamura, K.; Lee, C. P.; Smith, P. L.; Borchardt, R. T.; Hidalgo, I. J. Structure-affinity relationships of Val-Val and Val-Val-Val stereoisomers with the apical oligopeptide transporter in human intestinal Caco-2 cells. J. Drug Target 1998, 5, 317-327.
27. + co-transport system in the Caco-2 human colon carcinoma cell line. Biochem. J. 1994, 299, 253-260.
28. +/peptide cotransport system, PEPT1. Eur. J. Biochem. 1998, 255, 698-702.
29. Goodman, M.; Felix, A.; Moroder, L.; Toniolo, C. Synthesis of Peptides and Peptidomimetics. In Houben-Weyl Methods of Organic Chemistry; Georg Thieme: Stuttgart, New York, 2002.
30. SYBYL 6.7 and 6.8; Tripos Associates, Inc., 1699 South Hanley Rd., St. Louis, MO 63144.
31. Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity: A rapid access to atomic charges. Tetrahedron 1980, 36, 3219-3222.
32. Clark, M.; Cramer, R. D., III; Van Opdenbosch, N. The Tripos Field, J. Comput. Chem. 1989, 10, 982-1012.
33. Schinke, H. Ph.D. Dissertation, Martin-Luther-University Halle-Wittenberg, Halle, Germany, 1995.
34. Bohacek, R. S.; McMartin, C. Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surfaces: Validation of a high-resolution tool for drug design. J. Med. Chem. 1992, 35, 1671-1684.
35. Krömer, R. T.; Hecht, P. Replacement of steric 6-12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency. J. Comput.-Aided Mol. Des. 1995, 9, 205-212.
36. Böhm, M.; Stürzebecher, J.; Klebe, G. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J. Med. Chem. 1999, 42, 458-477.
37. Bush, B. L.; Nachbar, R. B., Jr. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J. Comput.-Aided Mol. Des. 1993, 7, 587-619.